Par Drugs and Chemicals Limited (NSE:PAR)

Market Cap	1.13B -44.2%
Revenue (ttm)	1.06B +4.8%
Net Income	139.06M -9.9%
EPS	11.31 -9.8%
Shares Out	12.30M
PE Ratio	8.15
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,112
Average Volume	10,438
Open	90.20
Previous Close	92.10
Day's Range	89.45 - 92.00
52-Week Range	81.01 - 122.43
Beta	-0.41
RSI	44.69
Earnings Date	Feb 10, 2026

About Par Drugs and Chemicals

Par Drugs and Chemicals Limited develops, manufactures, and sells active pharmaceutical ingredients (APIs) and fine chemicals in India. The company provides API products, including magnesium hydroxide, magnesium oxide USP, sucralfate, almagate BP, dried aluminium hydroxide gel, light magnesium carbonate, magaldrate, magnesium trisilicate, colloidal silicon dioxide, aluminium magnesium silicate, magnesium aluminometasilicate, magnesium aluminosilicate-USP, magnesium oxide light, magnesium oxide heavy, magnesium aluminium hydrate, hydrotalcite, a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1982
• Employees: 121
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: PAR

Financial Performance

In fiscal year 2025, Par Drugs and Chemicals's revenue was 1.01 billion, an increase of 5.58% compared to the previous year's 956.40 million. Earnings were 133.58 million, a decrease of -7.88%.